LCTX financials

Lineage Cell Therapeutics (LCTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

LCTX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$14.56M–-$36.62M-$63.53M-0.28
2024$9.50M$9.16M-$21.48M-$18.61M-0.09
2023$8.95M$8.27M-$24.73M-$21.49M-0.12
2022$14.70M$13.97M-$22.52M-$26.27M-0.15
2021$4.34M$2.92M-$49.21M-$43.02M-0.26
2020$1.83M$1.44M-$26.45M-$20.65M-0.14

Updated 2026-11-17 17:46 UTC